Caris Life Sciences, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $263,712 | $216,174 | $292,886 | $216,833 |
Gross Profit | 179,596 | 141,348 | 220,914 | 147,506 |
EBITDA | 15,152 | 17,230 | 97,604 | 42,702 |
EBIT | 8,614 | 12,165 | 93,313 | 37,832 |
Net Income | -637 | -510 | 81,957 | 24,325 |
Net Change In Cash | 263,712 | 216,174 | 292,886 | 216,833 |
Free Cash Flow | 28,936 | 22,534 | 39,690 | 55,330 |
Cash | 690,915 | 821,147 | 797,799 | 753,221 |
Basic Shares | 282,888 | 282,562 | 289,886 | 297,211 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $812,033 | $412,260 | $306,128 | $258,485 |
Gross Profit | 539,168 | 178,782 | 89,310 | 80,022 |
EBITDA | 11,380 | -182,952 | -260,804 | -245,894 |
EBIT | -11,235 | -231,865 | -309,805 | -294,147 |
Net Income | -537,957 | -281,890 | -341,415 | -320,827 |
Net Change In Cash | 812,033 | 412,260 | 306,128 | 258,485 |
Free Cash Flow | 66,895 | -253,643 | -298,419 | -327,961 |
Cash | 797,799 | 63,950 | 56,402 | 107,191 |
Basic Shares | 289,886 | 254,662 | 254,662 | 254,788 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.54 |
2026-03-31 | -$0.001 |
2025-12-31 | $0.28 |
2025-09-30 | $0.08 |